Table 1.
Demographics and clinical–pathological characteristics in PCD patients and control individuals.
| Controls (n = 35) | Patients (n = 35) | p-Value | |
|---|---|---|---|
| Age (years ± SD) | 26.73 ± 9.51 | 27.09 ± 20.12 | 0.226 |
| Male/female (n/%) | 17 (49%)/18 (51%) | 20 (57%)/15 (43%) | 0.632 |
| BMI (kg m−2) | 20.00 ± 2.00 | 22.53 ± 5.00 | 0.520 |
| Situs inversus (n/%) | - | 9 (26) | - |
| Chronic cough (n/%) | - | 31 (89) | - |
| Bronchiectasis (n/%) | - | 15 (43) | - |
| Atelectasis (n/%) | - | 11 (31) | - |
| Asthma (n/%) | - | 10 (29) | - |
| Otitis (n/%) | - | 21 (60) | - |
| Rhinosinusitis (n/%) | - | 18 (51) | - |
| Pneumonia (n/%) | - | 20 (57) | - |
| nNO (ppb) | - | 94.50 ± 64.50 | - |
Age is presented as mean and standard deviation. Sex is expressed as absolute values and as percentages of men and women. A comparison of proportions was performed using the chi-square test. Student’s t-test was used for mean comparison. A p-value < 0.05 was considered statistically significant. nNO: nasal nitric oxide; ppb: parts per billion.